# Efficacy and Safety Study of Moxidectin in Adults With Scabies

> **NCT05875441** · PHASE2 · COMPLETED · sponsor: **Medicines Development for Global Health** · enrollment: 200 (actual)

## Conditions studied

- Scabies

## Interventions

- **DRUG:** Moxidectin Oral Product
- **DRUG:** Moxidectin Oral Product
- **DRUG:** Moxidectin Oral Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05875441
- **Lead sponsor:** Medicines Development for Global Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-23
- **Primary completion:** 2024-11-27
- **Final completion:** 2025-02-11
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05875441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05875441, "Efficacy and Safety Study of Moxidectin in Adults With Scabies". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05875441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*